Etamsylate 125mg/mL, 2mL Injection

Etamsylate 125mg/mL injection is a haemostatic medicine used to reduce bleeding from small blood vessels, including selected perioperative bleeding situations. It supports capillary stability and platelet adhesion rather than dissolving a clot or reversing every anticoagulant.
A healthcare professional administers etamsylate by intravenous or intramuscular injection. Timing is selected around the bleeding episode or procedure; it is not swallowed or used on an oral-tablet schedule.
Etamsylate improves capillary wall stability and supports platelet adhesion at small blood vessels, helping reduce capillary bleeding and oozing.
Possible effects include nausea, abdominal discomfort, headache, skin rash, fever, dizziness, and low blood pressure symptoms. Serious warning signs include severe allergy, worsening bleeding, chest pain, leg swelling, severe headache, or fainting.
Bleeding cause should be assessed. Tell the clinician about clot history, porphyria, kidney/liver disease, pregnancy, breastfeeding, anticoagulants, antiplatelets, hormonal therapy, anemia, and any unexplained or postmenopausal bleeding.
Can reduce capillary bleeding and menstrual blood loss in selected patients while the underlying cause is assessed and managed.
It contains 125mg per millilitre and 250mg across the full 2mL ampoule. The amount in the ampoule is not automatically the amount required for every patient.
No. Heavy, unexplained, or emergency bleeding needs medical assessment and may need other treatment.
No. Etamsylate is a haemostatic medicine, not an anticoagulant.
Fainting, severe dizziness, very heavy bleeding, black stools, severe pain, or pregnancy-related bleeding needs urgent review.
Recurring heavy menstrual bleeding should be evaluated to identify the cause and rule out anemia or gynecologic disease.
Haemostatic: helps reduce bleeding; Capillary: a small blood vessel; Platelet adhesion: attachment of platelets at a damaged vessel; Etamsylate injection: an injectable haemostatic preparation; AR: Etamsylate 125mg حقن; FR: Etamsylate 125mg injection; PT: Etamsylate 125mg injeção; ES: Etamsylate 125mg inyección; RU: Etamsylate 125mg инъекция; ID: Etamsylate 125mg injeksi; VI: Etamsylate 125mg thuốc tiêm; MS: Etamsylate 125mg suntikan; TL: Etamsylate 125mg iniksyon; ZH-SG: Etamsylate 125mg 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Etamsylate 125mg/mL, 2mL Injection under Blood Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Etamsylate 125mg/mL, 2mL Injection